These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 38831091

  • 1. Effects of renal denervation on blood pressure in patients with hypertension: a latest systematic review and meta-analysis of randomized sham-controlled trials.
    Ogoyama Y, Abe M, Okamura K, Tada K, Katsurada K, Shibata S, Kai H, Rakugi H, Node K, Yokoi H, Kario K, Arima H.
    Hypertens Res; 2024 Oct; 47(10):2745-2759. PubMed ID: 38831091
    [Abstract] [Full Text] [Related]

  • 2. Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials.
    Ogoyama Y, Tada K, Abe M, Nanto S, Shibata H, Mukoyama M, Kai H, Arima H, Kario K.
    Hypertens Res; 2022 Feb; 45(2):210-220. PubMed ID: 34657140
    [Abstract] [Full Text] [Related]

  • 3. Randomized Trials of Renal Denervation for Uncontrolled Hypertension: An Updated Meta-Analysis.
    Mufarrih SH, Qureshi NQ, Khan MS, Kazimuddin M, Secemsky E, Bloch MJ, Giri J, Cohen D, Swaminathan RV, Feldman DN, Alaswad K, Kirtane A, Kandzari D, Aronow HD.
    J Am Heart Assoc; 2024 Aug 20; 13(16):e034910. PubMed ID: 39140334
    [Abstract] [Full Text] [Related]

  • 4. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.
    Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, Schmieder RE, Janas AJ, Langer C, Persu A, Mendelsohn FO, Ameloot K, Foster M, Fischell TA, Parise H, Mahfoud F.
    Circulation; 2024 Jun 11; 149(24):1875-1884. PubMed ID: 38587557
    [Abstract] [Full Text] [Related]

  • 5. Intravascular Renal Denervation Reduces Ambulatory and Office Blood Pressure in Patients with Essential Hypertension: A Meta-Analysis of Randomized Sham-Controlled Trials.
    Yang X, Liu H, Chen S, Dong P, Zhao D.
    Kidney Blood Press Res; 2022 Jun 11; 47(6):363-374. PubMed ID: 35385842
    [Abstract] [Full Text] [Related]

  • 6. Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial.
    Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Brar S, Hettrick DA, Fahy M, Böhm M.
    Hypertens Res; 2023 Jan 11; 46(1):280-288. PubMed ID: 36241705
    [Abstract] [Full Text] [Related]

  • 7. The effect of catheter-based sham renal denervation in hypertension: systematic review and meta-analysis.
    Fernandes A, David C, Pinto FJ, Costa J, Ferreira JJ, Caldeira D.
    BMC Cardiovasc Disord; 2023 May 12; 23(1):249. PubMed ID: 37173636
    [Abstract] [Full Text] [Related]

  • 8. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
    Mathiassen ON, Vase H, Bech JN, Christensen KL, Buus NH, Schroeder AP, Lederballe O, Rickers H, Kampmann U, Poulsen PL, Hansen KW, Btker HE, Peters CD, Engholm M, Bertelsen JB, Lassen JF, Langfeldt S, Andersen G, Pedersen EB, Kaltoft A.
    J Hypertens; 2016 Aug 12; 34(8):1639-47. PubMed ID: 27228432
    [Abstract] [Full Text] [Related]

  • 9. Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial.
    Böhm M, Mahfoud F, Townsend RR, Kandzari DE, Pocock S, Ukena C, Weber MA, Hoshide S, Patel M, Tyson CC, Weil J, Agdirlioglu T, Fahy M, Kario K.
    Eur Heart J; 2019 Mar 01; 40(9):743-751. PubMed ID: 30608521
    [Abstract] [Full Text] [Related]

  • 10. Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis.
    Vukadinović D, Lauder L, Kandzari DE, Bhatt DL, Kirtane AJ, Edelman ER, Schmieder RE, Azizi M, Böhm M, Mahfoud F.
    Circulation; 2024 Nov 12; 150(20):1599-1611. PubMed ID: 39355923
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial.
    Jiang X, Mahfoud F, Li W, Dong H, Yu J, Yu S, Chen X, Wang P, Li Z, Lauder L, Wang Z, Ji Z, Dong Y, Han B, Zhu Z, Chen Y, Xu J, Zhao X, Fan W, Xie W, Hubbard B, Hu X, Kario K, Gao R.
    Circulation; 2024 Nov 12; 150(20):1588-1598. PubMed ID: 39229700
    [Abstract] [Full Text] [Related]

  • 12. Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis.
    Fadl Elmula FEM, Feng YM, Jacobs L, Larstorp AC, Kjeldsen SE, Persu A, Staessen JA, European Network COordinating research on Renal Denervation (ENCOReD).
    Blood Press; 2017 Aug 12; 26(4):195-203. PubMed ID: 28443356
    [Abstract] [Full Text] [Related]

  • 13. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Circulation; 2013 Jul 09; 128(2):132-40. PubMed ID: 23780578
    [Abstract] [Full Text] [Related]

  • 14. Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study.
    Gosse P, Cremer A, Kirtane AJ, Lobo MD, Saxena M, Daemen J, Wang Y, Stegbauer J, Weber MA, Abraham J, Kario K, Bangalore S, Claude L, Liu Y, Azizi M.
    Hypertension; 2021 Feb 09; 77(2):529-536. PubMed ID: 33356403
    [Abstract] [Full Text] [Related]

  • 15. The effect of renal denervation on resistant hypertension: Meta-analysis of randomized controlled clinical trials.
    Yao Y, Zhang D, Qian J, Deng S, Huang Y, Huang J.
    Clin Exp Hypertens; 2016 Feb 09; 38(3):278-86. PubMed ID: 27018652
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.
    Wang J, Yin Y, Lu C, Lu Z, Hu J, Wang Y, Ge J, Jiang H, Yao C, Yan X, Ma W, Qi X, Dang Y, Chen S, Zhu J, Wang D, Ding C, Wang W, Liu J, Wang Y, Li H, Pan Z, Cui K, Li C, Liang X, Chen W, Sobotka PA, Zhang J, Esler M, Sun N, Chen M, Huo Y.
    EClinicalMedicine; 2024 Jun 09; 72():102626. PubMed ID: 38756107
    [Abstract] [Full Text] [Related]

  • 17. What are the ideal metrics for assessing the quality of long-term stabilized "perfect" 24-h BP control after renal denervation?
    Kario K.
    Hypertens Res; 2024 Oct 09; 47(10):2644-2651. PubMed ID: 39191961
    [Abstract] [Full Text] [Related]

  • 18. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.
    Hypertension; 2014 May 09; 63(5):991-9. PubMed ID: 24591332
    [Abstract] [Full Text] [Related]

  • 19. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.
    Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, O'Neill WW, Patel MR, Rocha-Singh K, Sobotka PA, Svetkey L, Townsend RR, Bakris GL.
    Eur Heart J; 2015 Jan 21; 36(4):219-27. PubMed ID: 25400162
    [Abstract] [Full Text] [Related]

  • 20. Effects of catheter-based renal denervation in hypertension: a systematic review and meta-analysis.
    Vukadinović D, Lauder L, Kandzari DE, Bhatt DL, Kirtane A, Edelman ER, Schmieder RE, Azizi M, Böhm M, Mahfoud F.
    medRxiv; 2024 Jun 17. PubMed ID: 38946962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.